Amgen’s muscular disorder drug meets main goal in latestage study
Sep 24, 2024
Amgen said on Tuesday that its drug helped improve daily activities including chewing and swallowing in patients suffering from a rare muscle-weakening disease, meeting the main goal of a late-stage study.
https://www.staradvertiser.com/2024/09/24/breaking-news/amgens-muscular-disorder-drug-meets-main-goal-in-late-stage-study/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service